Eosinophilic esophagitis: Is it a common cause of food impaction?
PDF
Cite
Share
Request
Original Article
VOLUME: 27 ISSUE: 2
P: 78 - 81
June 2011

Eosinophilic esophagitis: Is it a common cause of food impaction?

Turk J Surg 2011;27(2):78-81
1. Özel Bodrum Hastanesi, Genel Cerrahi, Muğla, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

Abstract

Purpose: The objective of the present study was to examine the incidence and therapeutic options for eosinophilic oesophagitis, which is a condition characterised by eosinophilic infiltration of the oesophagus and has attracted more attention recently as a possible cause of food impaction in the oesophagus. Patients and Methods: In this study, of the 44 cases admitted to our emergency room with oesophageal food impaction between 2005 and 2010, 28 were found to have histopathologically documented eosinophilic oesophagitis. Results: Obstruction in the oesophagus caused by food, which is also referred to as “Steakhouse Syndrome”, was associated with a malignancy only in one patient who had a distal oesophageal tumor. Thirty patients had some type of gastrointestinal signs or symptoms including difficult swallowing, nausea, vomitting, or reflux before the occurrence of the event. Mucosal lesions were present in 30 subjects. Samples for biopsy were taken from different oesophageal sites in all patients which showed intense eosinophilic infiltration in 28 patient, with 20 to 30 and >30 eosinophils per high-power field in 12 and 16 patients, respectively. Conclusion: Eosinophilic infiltration, common in middle-aged Caucasian males, usually presents with retrosternal pain, hypersalivation, and inability to swallow and has emerged as the most common cause of oesophageal food impaction in the present study. We believe that in patients presenting with food impaction physicians should maintain a high index of suspicion for a possible diagnosis of eosinophilic oesophagitis and perform oesophageal biopsy at multiple sites in order to implement an effective treatment.

Keywords:
Eosinophilic esophagitis, food impaction

References

1
Landers R, Kuster GGR, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology1978; 74: 1298-1301.
2
Attwood SE, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109-116. DOI:10.1007/BF01296781
3
Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115:418–419. DOI:10.1016/j.jaci.2004.11.006
4
Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006; 18:211-217. DOI:10.1097/00042737- 200602000-00015
5
Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109:1503-1512. DOI:10.1016/0016-5085(95)90637-1
6
Furuta GT, Straumann A. Eosinophilic esophagitis: an emerging clinicopathologic disease of children and adults. Gastroenterol Hepatol 2006; 2: 371-374.
7
Straumann A, Degen L, Felder S, et al. Budesonide as induction treatment for active eosinophilic esophagitis in adolescents and adults: a randomized, doubleblind, placebo-controlled study. Gastroenterology 2008; 134:A-104. DOI:10.1016/ S0016-5085(08)60488-6
8
Straumann A, Bussmann C, Zuber M, et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008; 6:598–600. DOI:10.1016/j.cgh.2008.02.003
9
Liacouras CA, Wenner WJ, Brown K, et al. Primary eosinophilic esophagitis in children: successful treatmentwith oral corticosteroids. J Pediatr Gastroenterol Nutr 1998;26:380–385.
10
Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131:1381-1391. DOI:10.1053/j.gastro.2006.08.033
11
Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118:1312–1319. DOI:10.1016/j.jaci.2006.09.007
12
Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006;4:1097-1102. DOI:10.1016/j. cgh.2006.05.026